Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Lassman

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1974
Biochemical pharmacology of the fibrinolysin system of the rat. 3. The mechanism of phenformin (1-(beta-phenethyl)-biguanide)-induced fibrinolytic activityH B Lassman, N Back
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1974
Biochemical pharmacology of the fibrinolysin system of the rat. II. The effect of insulin induced hypoglycemiaH B Lassman, N Back
Diagnostic Microbiology and Infectious Disease|June 1, 1984
Metabolism of cefotaxime: a reviewH B Lassman, J D Coombes
The Journal of Antimicrobial Chemotherapy|November 1, 1987
Roxithromycin: a pharmacokinetic review of a macrolideS K Puri, H B Lassman
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1974
Biochemical pharmacology of the fibrinolysin system of the rat. I. The effect of alloxan-induced hyperglycemiaH B Lassman, H J Wilkens, N Back
Journal of Medicinal Chemistry|November 1, 1977
Dibenz[b,e]oxepinalkanoic acids as nonsteroidal antiinflammatory agents. 3. omega-(6,11-Dihydro-11-oxodibenz[b,e]oxepin-2-yl)alkanoic acidsD E Aultz, A R McFadden, H B Lassman
The New England Journal of Medicine|February 26, 1981
FendosalH B Lassman, R C Allen, W J Novick
Pharmacological Research Communications|October 1, 1974
Alterations in platelet aggregation associated with adjuvant arthritis in ratsH B Lassman, R E Kirby, W J Novick
Journal of Clinical Pharmacology|October 1, 1990
Multiple dose pharmacokinetics, safety, and tolerance of velnacrine (HP 029) in healthy elderly subjects: a potential therapeutic agent for Alzheimer's diseaseS K Puri, I Ho, R Hsu, et al.
Journal of Clinical Pharmacology|October 1, 1989
The effect of food on the bioavailability of velnacrine (HP 029) in healthy elderly men: a potential Alzheimer agentS K Puri, R S Hsu, I Ho, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1974
Biochemical pharmacology of the fibrinolysin system of the rat. 3. The mechanism of phenformin (1-(beta-phenethyl)-biguanide)-induced fibrinolytic activityH B Lassman, N Back
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1974
Biochemical pharmacology of the fibrinolysin system of the rat. II. The effect of insulin induced hypoglycemiaH B Lassman, N Back
Diagnostic Microbiology and Infectious Disease|June 1, 1984
Metabolism of cefotaxime: a reviewH B Lassman, J D Coombes
The Journal of Antimicrobial Chemotherapy|November 1, 1987
Roxithromycin: a pharmacokinetic review of a macrolideS K Puri, H B Lassman
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1974
Biochemical pharmacology of the fibrinolysin system of the rat. I. The effect of alloxan-induced hyperglycemiaH B Lassman, H J Wilkens, N Back
Journal of Medicinal Chemistry|November 1, 1977
Dibenz[b,e]oxepinalkanoic acids as nonsteroidal antiinflammatory agents. 3. omega-(6,11-Dihydro-11-oxodibenz[b,e]oxepin-2-yl)alkanoic acidsD E Aultz, A R McFadden, H B Lassman
The New England Journal of Medicine|February 26, 1981
FendosalH B Lassman, R C Allen, W J Novick
Pharmacological Research Communications|October 1, 1974
Alterations in platelet aggregation associated with adjuvant arthritis in ratsH B Lassman, R E Kirby, W J Novick
Journal of Clinical Pharmacology|October 1, 1990
Multiple dose pharmacokinetics, safety, and tolerance of velnacrine (HP 029) in healthy elderly subjects: a potential therapeutic agent for Alzheimer's diseaseS K Puri, I Ho, R Hsu, et al.
Journal of Clinical Pharmacology|October 1, 1989
The effect of food on the bioavailability of velnacrine (HP 029) in healthy elderly men: a potential Alzheimer agentS K Puri, R S Hsu, I Ho, et al.
Pageof 3